Company CALYXTPAR

Equities

CLXT

US13173L2060

Advanced Medical Equipment & Technology

End-of-day quote Nasdaq 06:00:00 2024-02-04 pm EST 5-day change 1st Jan Change
17.59 USD -.--% Intraday chart for CALYXTPAR +2.93% -10.44%

Business Summary

Cibus, Inc. is an agricultural technology company that uses gene editing technologies to develop plant traits in seeds. Its business is the development of plant traits that help address specific productivity or yield challenges in farming, such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate. It is also engaged in developing, certain alternative plant-based oils or bio-based fermentation products. Its technology is its gene editing platform called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits, four of which are applicable to multiple crops. These traits are PSR in Canola and HT1 and HT3 in rice. In addition, it also has two advanced traits for Sclerotinia resistance and another novel broadleaf HT trait, HT2.

Sales per Business

USD in Million2021Weight2022Weight Delta
Other
100.0 %
0 0.2 % 0 100.0 % +175.44%

Sales per region

USD in Million2021Weight2022Weight Delta
United States
100.0 %
26 100.0 % 0 100.0 % -99.40%

Managers

Managers TitleAgeSince
Chief Executive Officer 71 -
Director of Finance/CFO 67 -
President 61 -
Chief Tech/Sci/R&D Officer 55 -
General Counsel - 23-08-02

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 71 -
Director/Board Member 81 -
Director/Board Member 76 -
President 61 -
Director/Board Member 82 -
Director/Board Member 85 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 3,142,636 0 0 77.43 %
Stock B 1 22,295,402 17,262,255 ( 77.43 %) 672,723 ( 3.017 %)

Shareholders

NameEquities%Valuation
Rory Riggs
14.92 %
3,132,095 14.92 % 70 M $
Fidelity Management & Research Co. LLC
13.44 %
2,820,995 13.44 % 63 M $
1,687,071 8.038 % 38 M $
Mark Finn
6.455 %
1,354,807 6.455 % 30 M $
Vantage Consulting Group, Inc.
5.450 %
1,143,949 5.450 % 26 M $
Vanguard Global Advisers LLC
3.316 %
695,928 3.316 % 16 M $
479,264 2.283 % 11 M $
Wade King
1.011 %
212,100 1.011 % 5 M $
BlackRock Institutional Trust Co. NA
0.9684 %
203,263 0.9684 % 5 M $
Geode Capital Management LLC
0.7646 %
160,488 0.7646 % 4 M $
NameEquities%Valuation
1,518,015 - 34 M $
1,388,084 - 31 M $
14,518 - 326 074 $
8,556 - 192 168 $
3,503 - 78 677 $
NameEquities%Valuation
1,518,015 - 34 M $
1,382,117 - 31 M $
14,518 - 326 074 $
8,556 - 192 168 $
3,503 - 78 677 $

Company contact information

Cibus, Inc.

6455 Nancy Ridge Drive

92121, San Diego

+

http://cibus.com
address CALYXTPAR(CLXT)